©The Author(s) 2016.
World J Gastrointest Pharmacol Ther. Feb 6, 2016; 7(1): 33-40
Published online Feb 6, 2016. doi: 10.4292/wjgpt.v7.i1.33
Published online Feb 6, 2016. doi: 10.4292/wjgpt.v7.i1.33
Table 4 Extrahepatic manifestations associated with hepatitis C virus infection
| Neuropsychiatric | Ocular |
| Depression | Corneal ulcer |
| Cerebral vasculitis | Uveitis |
| Endocrine | Autoimmune phenomena |
| hypothyroidism | CREST syndrome |
| Diabetes mellitus | Thyroiditis/hypothyroidism |
| Thyroiditis | Sicca syndrome |
| Neuromuscular | Renal |
| Weakness/myalgia | Membranous glomerulonephritis |
| Peripheral neuropathy | Nephrotic syndrome |
| Arthritis/arthralgia | Cryoglobulinemia related glomerulonephritis |
| Vascular | Hematologic |
| Necrotizing vasculitis | Aplastic anemia |
| Polyarteritis nodosa | Thrombocytopenia |
| Cryoglobulinemia | Non-Hodgkin’s B cell lymphoma |
| Dermatologic | |
| Porphyria cutanea tarda | |
| Lichen planus | |
| Cutaneous necrotizing vasculitis | |
| Livedo reticularis |
- Citation: Attar BM, Van Thiel DH. Hepatitis C virus: A time for decisions. Who should be treated and when? World J Gastrointest Pharmacol Ther 2016; 7(1): 33-40
- URL: https://www.wjgnet.com/2150-5349/full/v7/i1/33.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v7.i1.33